UAE-based E-Script Medicine Management Company Pharmak Direct And AHI Extend Master Services Agreement
UAE-based E-Script Medicine Management Company Pharmak Direct And AHI Extend Master Services Agreement
Advanced Health Intelligence Ltd (NASDAQ:AHI) ("AHI" or "the Company") is pleased to inform shareholders that the Company has extended the previously executed Master Services Agreement ("MSA") with Pharmak Direct, allowing the parties additional time to integrate the solutions, as set out in the terms and conditions of the MSA between AHI and Pharmak Direct. All other terms and conditions have remained the same, and the parties will work together over the 90-day extension to conclude integration and release in accordance with the previously executed MSA.
Advanced Health Intelligence Ltd（納斯達克股票代碼：AHI）（“AHI” 或 “公司”）很高興地告知股東，公司已延長先前與Pharmak Direct簽署的主服務協議（“MSA”），使雙方有更多時間整合解決方案，如AHI和Pharmak Direct之間的MSA條款和條件所述。所有其他條款和條件保持不變，雙方將在90天的延期內共同努力，根據先前執行的MSA完成整合和發佈。
譯文內容由第三人軟體翻譯。